Innovations in Thrombosis and Hemostasis: A Glimpse Towards the Future of Diagnostic Analyzers

Elizabeth M. Van Cott; Kristi J. Smock; Giuseppe Lippi

doi:10.1055/s-0039-1683844

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2019; 45(03): 225-227
DOI: 10.1055/s-0039-1683844

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Innovations in Thrombosis and Hemostasis: A Glimpse Towards the Future of Diagnostic Analyzers

Elizabeth M. Van Cott

¹Coagulation Laboratory, Massachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts

,

Kristi J. Smock

²ARUP Hemostasis/Thrombosis Laboratory, University of Utah School of Medicine, Salt Lake City, Utah

,

Giuseppe Lippi

³Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona, Verona, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Favaloro EJ, Lippi G. Recent advances in mainstream hemostasis diagnostics and coagulation testing. Semin Thromb Hemost 2019; 45 (03) 228-246
2 Cuker A, Marturano JE, Carinato ME, Lowery TJ, Cines DB. T2 magnetic resonance to monitor hemostasis. Semin Thromb Hemost 2019; 45 (03) 247-252
3 Harder S, Santos SMD, Krozer V, Moll J. Surface acoustic wave-based microfluidic coagulation device for monitoring anticoagulant therapy. Semin Thromb Hemost 2019; 45 (03) 253-258
4 Ansell J, Zappe S, Jiang X. , et al. A novel whole blood point-of-care coagulometer to measure the effect of direct oral anticoagulants and heparins. Semin Thromb Hemost 2019; 45 (03) 259-263
5 Nadkarni SK. Comprehensive coagulation profiling at the point-of-care using a novel laser-based approach. Semin Thromb Hemost 2019; 45 (03) 264-274
6 Harenberg J, Schreiner R, Hetjens S, Weiss C. Detecting anti-IIa and anti-Xa direct oral anticoagulant (DOAC) agents in urine using a DOAC Dipstick. Semin Thromb Hemost 2019; 45 (03) 275-284
7 Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost 2012; 38 (06) 565-575
8 Lippi G, Favaloro EJ. Preanalytical issues in hemostasis and thrombosis testing. Methods Mol Biol 2017; 1646: 29-42
9 Williams EK, Oshinowo O, Ravindran A, Lam WA, Myers DR. Feeling the force: measurements of platelet contraction and their diagnostic implications. Semin Thromb Hemost 2019; 45 (03) 285-296
10 Silva RL, Grabowski EF. Flow devices to assess platelet function: a comparison of devices past, present and future. Semin Thromb Hemost 2019; 45 (03) 297-301
11 Emani SM. Novel coagulation analyzers in development: a glimpse toward the future of microfluidics. Semin Thromb Hemost 2019; 45 (03) 302-307
12 Lippi G, Salvagno GL, Gelati M, Poli G, Giavarina D, Favaloro EJ. Analytical assessment of the new Roche cobas t 711 analyzer fully-automated coagulation analyzer. Semin Thromb Hemost 2019; 45 (03) 308-314
13 Lippi G, Salvagno GL, Poli G, Gelati M, Favaloro EJ. Assessment of plasma sample quality on Siemens Atellica COAG 360 System. Semin Thromb Hemost 2019; 45 (03) 315-318
14 Bonar RA, Lippi G, Favaloro EJ. Overview of hemostasis and thrombosis and contribution of laboratory testing to diagnosis and management of hemostasis and thrombosis disorders. Methods Mol Biol 2017; 1646: 3-27
15 Favaloro EJ. Diagnosis or exclusion of von Willebrand disease using laboratory testing. Methods Mol Biol 2017; 1646: 391-402
16 Favaloro EJ. Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease. Am J Hematol 2017; 92 (01) 114-118
17 Favaloro EJ, Mohammed S, Oliver S. The increasing maturity of the von Willebrand factor collagen binding in von Willebrand disease diagnosis. Haemophilia 2018; 24 (01) 20-23
18 Patzke J, Favaloro EJ. Laboratory testing for von Willebrand factor activity by glycoprotein Ib binding assays (VWF:GPIb). Methods Mol Biol 2017; 1646: 453-460
19 Oliver S, Lau KKE, Chapman K, Favaloro EJ. Laboratory testing for von Willebrand factor multimers. Methods Mol Biol 2017; 1646: 495-511
20 Higgins RA, Goodwin AJ. Automated assays for von Willebrand factor activity. Am J Hematol 2018;
21 Favaloro EJ, Bonar R, Hollestelle MJ. , et al. Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: a large international cross-laboratory study. Thromb Res 2018; 166: 96-105
22 Favaloro EJ, McCaughan G, Mohammed S. , et al. HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia. Pathology 2018; 50 (04) 426-436
23 Favaloro EJ. Laboratory tests for identification or exclusion of heparin induced thrombocytopenia: HIT or miss?. Am J Hematol 2018; 93 (02) 308-314
24 Mitta A, Curtis BR, Reese JA, George JN. Drug-induced thrombocytopenia: 2019 update of clinical and laboratory data. Am J Hematol 2019; 94 (03) E76-E78
25 Rodeghiero F. A hit to current “hit” wisdom: a century later, it's time for a change. Am J Hematol 2017; 92 (08) 727-729
26 Favaloro EJ, McCaughan G, Pasalic L. Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update. Pathology 2017; 49 (04) 346-355
27 Favaloro EJ, Gosselin R, Olson J, Jennings I, Lippi G. Recent initiatives in harmonization of hemostasis practice. Clin Chem Lab Med 2018; 56 (10) 1608-1619
28 Ayanambakkam A, Kremer Hovinga JA, Vesely SK, George JN. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol 2017; 92 (11) E644-E646
29 Labarque V, Perinparajah V, Bouskill V. , et al. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A. Am J Hematol 2017; 92 (06) E94-E96
30 Saleem R, Reese JA, George JN. Drug-induced thrombotic microangiopathy: an updated systematic review, 2014-2018. Am J Hematol 2018; 93 (09) E241-E243
31 Favaloro EJ. Clinical utility of closure times using the platelet function analyzer-100/200. Am J Hematol 2017; 92 (04) 398-404